Crankshaw D J, Rangachari P K
Honours Biology-Pharmacology Coop Program, Department of Obstetrics and Gynecology, McMaster University, Hamilton, Ontario, Canada.
Mol Cell Biochem. 2003 Nov;253(1-2):125-30. doi: 10.1023/a:1026052123843.
Isoprostanes are members of a family of prostaglandin isomers that are produced by free radical-catalysed mechanisms. They have become well-recognized indicators of oxidant-induced cell damage in a variety of pathophysiological conditions. Several isoprostanes have been shown to possess biological activity in whole-animal, isolated tissue and cell-based systems. Their actions include vasoconstriction, platelet aggregation and cardiac hypertrophy. Current evidence suggests that these effects are mediated by prostanoid receptors through a complex set of interactions that involve agonism, partial agonism, desensitization and co-operative behaviors. It is likely that other mechanisms of action are waiting to be discovered. Based on a consideration of these biological effects, we argue that isoprostanes are more than mere markers and may serve as active participants in promoting and exaggerating pathophysiological changes. To tease out their roles requires considerable more work and a willingness to suspend disbelief based on limited evidence.
异前列腺素是前列腺素异构体家族的成员,由自由基催化机制产生。在多种病理生理条件下,它们已成为氧化应激诱导细胞损伤的公认指标。已有研究表明,几种异前列腺素在整体动物、离体组织和细胞系统中具有生物活性。它们的作用包括血管收缩、血小板聚集和心脏肥大。目前的证据表明,这些效应是由前列腺素受体通过一系列复杂的相互作用介导的,这些相互作用涉及激动作用、部分激动作用、脱敏作用和协同行为。很可能还有其他作用机制有待发现。基于对这些生物学效应的考虑,我们认为异前列腺素不仅仅是单纯的标志物,它们可能是促进和加剧病理生理变化的积极参与者。要弄清楚它们的作用,还需要进行大量的研究工作,并且要有基于有限证据而暂时放下疑虑的意愿。